• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

前列腺特异性抗原前体在前列腺癌诊断中的应用价值。

Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.

作者信息

Filella Xavier, Alcover Joan, Molina Rafael, Luque Pilar, Corral Juan M, Augé Josep M, Coca Francisca

机构信息

Department of Biochemistry and Molecular Genetics, Hospital Clinic, Barcelona, Catalonia, Spain.

出版信息

Anticancer Res. 2007 Jan-Feb;27(1B):607-10.

PMID:17348449
Abstract

BACKGROUND

Free prostate-specific antigen (fPSA), the minor form of total PSA, contains different molecular subforms, including BPSA and proPSA. Whereas BPSA is associated with benign prostate hyperplasia, proPSA is associated with prostate tumor.

PATIENTS AND METHODS

The serum levels of PSA, fPSA and proPSA were measured using automated electrochemiluminescent immunoassays (Elecsys 2010, Roche Diagnostics) in 87 patients with prostate cancer and 138 patients with benign prostate hyperplasia. Also, we calculated the derived tests of these assays through the subtraction or the ratio between the measured tests.

RESULTS

Receiver operating characteristics curves were used for comparison of the diagnostic utility of tests assessed. The biggest areas were obtained for the free/total PSA ratio (0.705), the calculated Bfree PSA/total PSA ratio (0.719) and the calculated Bfree PSA/bound PSA ratio (0. 726).

CONCLUSION

Applying a multivariate logistic regression analysis, it was determined that the combination of the proPSA concentration, the proPSA/total PSA ratio and the calculated Bfreeltotal PSA ratio improves the area under the curve obtained for individual tests (0.753). ProPSA may be useful in the diagnosis of prostate cancer.

摘要

背景

游离前列腺特异性抗原(fPSA)是总PSA的次要形式,包含不同的分子亚形式,包括BPSA和proPSA。BPSA与良性前列腺增生相关,而proPSA与前列腺肿瘤相关。

患者和方法

使用自动化电化学发光免疫分析法(Elecsys 2010,罗氏诊断公司)测定了87例前列腺癌患者和138例良性前列腺增生患者的血清PSA、fPSA和proPSA水平。此外,我们通过测量值之间的减法或比值计算了这些检测的衍生指标。

结果

采用受试者工作特征曲线比较所评估检测的诊断效用。游离/总PSA比值(0.705)、计算得到的B游离PSA/总PSA比值(0.719)和计算得到的B游离PSA/结合PSA比值(0.726)的曲线下面积最大。

结论

应用多因素逻辑回归分析确定,proPSA浓度、proPSA/总PSA比值与计算得到的B游离/总PSA比值的组合可提高各单项检测的曲线下面积(0.753)。ProPSA可能有助于前列腺癌的诊断。

相似文献

1
Usefulness of proprostate-specific antigen in the diagnosis of prostate cancer.前列腺特异性抗原前体在前列腺癌诊断中的应用价值。
Anticancer Res. 2007 Jan-Feb;27(1B):607-10.
2
Evaluation of proprostate specific antigen for early detection of prostate cancer in men with a total prostate specific antigen range of 4.0 to 10.0 ng/ml.在总前列腺特异性抗原范围为4.0至10.0 ng/ml的男性中,评估游离前列腺特异性抗原用于前列腺癌早期检测的情况。
J Urol. 2003 Sep;170(3):723-6. doi: 10.1097/01.ju.0000086940.10392.93.
3
Tumor-associated forms of prostate specific antigen improve the discrimination of prostate cancer from benign disease.肿瘤相关形式的前列腺特异性抗原可提高前列腺癌与良性疾病的鉴别能力。
Rinsho Byori. 2004 Mar;52(3):223-30.
4
Free to complexed PSA ratio in differentiating benign prostate hyperplasia from prostate cancer.游离前列腺特异性抗原与复合前列腺特异性抗原比值在鉴别良性前列腺增生与前列腺癌中的应用
Anticancer Res. 2001 Sep-Oct;21(5):3717-20.
5
Comparison of several combinations of free, complexed, and total PSA in the diagnosis of prostate cancer in patients with urologic symptoms.比较游离前列腺特异性抗原(PSA)、复合PSA和总PSA的几种组合在诊断有泌尿系统症状患者前列腺癌中的作用。
Urology. 2004 Jun;63(6):1100-3; discussion 1103-4. doi: 10.1016/j.urology.2004.01.056.
6
Clinical utility of proPSA and "benign" PSA when percent free PSA is less than 15%.当游离前列腺特异抗原(fPSA)百分比低于15%时,前列腺特异抗原(proPSA)和“良性”前列腺特异抗原(PSA)的临床应用价值
Urology. 2004 Dec;64(6):1160-4. doi: 10.1016/j.urology.2004.06.033.
7
Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.血清人腺体激肽释放酶(hK2)和胰岛素样生长因子1(IGF-1)与总前列腺特异性抗原(PSA)和游离PSA百分比相结合,可提高前列腺癌与良性前列腺增生之间的鉴别能力。
Prostate. 2003 Feb 15;54(3):220-9. doi: 10.1002/pros.10186.
8
Serum (-5, -7) proPSA for distinguishing stage and grade of prostate cancer.血清(-5,-7)前列腺特异性抗原前体用于区分前列腺癌的分期和分级。
Anticancer Res. 2007 Jul-Aug;27(4A):1833-6.
9
Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.在没有前列腺癌的男性中,血清总前列腺特异性抗原(BPSA)作为前列腺增大的预测指标,其表现优于总前列腺特异性抗原(total PSA)和游离前列腺特异性抗原(free PSA)。
Urology. 2004 May;63(5):905-10; discussion 910-1. doi: 10.1016/j.urology.2003.12.037.
10
A (-5, -7) proPSA based artificial neural network to detect prostate cancer.一种基于-5,-7前列腺特异性抗原(proPSA)的人工神经网络用于检测前列腺癌。
Eur Urol. 2006 Nov;50(5):1014-20. doi: 10.1016/j.eururo.2006.04.011. Epub 2006 May 2.

引用本文的文献

1
Systematic Differences Between Total and Free Prostate-Specific Antigen Immunoassays: Comparison Using Passing and Bablok Regression.总前列腺特异性抗原和游离前列腺特异性抗原免疫测定之间的系统差异:使用帕辛和巴布洛克回归法进行比较
Indian J Clin Biochem. 2021 Apr;36(2):151-158. doi: 10.1007/s12291-019-0818-6. Epub 2019 Feb 13.